Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights

Prodigiosin, a secondary metabolite red pigment produced by Serratia marcescens, has an interesting apoptotic efficacy against cancer cell lines with low or no toxicity on normal cells. HSP90α is known as a crucial and multimodal target in the treatment of TNBC. Our research attempts to assess the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Anwar, Mohammed Moustapha, Shalaby, Manal, Embaby, Amira M., Saeed, Hesham, Agwa, Mona M., Hussein, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477571/
https://www.ncbi.nlm.nih.gov/pubmed/32895397
http://dx.doi.org/10.1038/s41598-020-71157-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477571/
https://www.ncbi.nlm.nih.gov/pubmed/32895397
http://dx.doi.org/10.1038/s41598-020-71157-w

Ejemplares similares